CoChat

The stress-responsive gene GDPGP1/mcp-1 regulates neuronal glycogen metabolism and survival

Open access

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Maladaptive responses to stress might play a role in the sensitivity of neurons to stress. To identify novel cellular responses to stress, we performed transcriptional analysis in acutely stressed mouse neurons, followed by functional characterization in Caenorhabditis elegans. In both contexts, we found that the gene GDPGP1/mcp-1 is down-regulated by a variety of stresses. Functionally, the enzyme GDPGP1/mcp-1 protects against stress. Knockdown of GDPGP1 in mouse neurons leads to widespread neuronal cell death. Loss of mcp-1, the single homologue of GDPGP1 in C. elegans, leads to increased degeneration of GABA neurons as well as reduced survival of animals following environmental stress. Overexpression of mcp-1 in neurons enhances survival under hypoxia and protects against neurodegeneration in a tauopathy model. GDPGP1/mcp-1 regulates neuronal glycogen levels, indicating a key role for this metabolite in neuronal stress resistance. Together, our data indicate that down-regulation of GDPGP1/mcp-1 and consequent loss of neuronal glycogen is a maladaptive response that limits neuronal stress resistance and reduces survival.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1083/jcb.201807127

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. RNA-seq identifies the transcriptomic signature of acutely injured neurons. (A) Experimental design to generate a common transcriptomic signature of acutely injured primary mouse neurons. DIV7 neurons prepared from E17 mice were exposed to either OGD or KA. Differentially expressed genes (corrected P values ≤0.01) were determined for each condition. (B) Of 318 similarly regulated and statistically significant genes, 210 were found to be down-regulated and 108 up-regulated due to acute neuronal injury in both in vitro assays. (C) The top 10 up-regulated (blue) and down-regulated (red) genes identified as shared transcriptional signature of acutely injured neurons are depicted along with the mean log2 fold change (FC) and the individual FC for OGD and KA. (D) Flow chart illustrating the selection of identified genes for in vivo validation in C. elegans. (E) Graph indicating the results for 45 individual C. elegans mutant strains with regard to their survival during 48-h period of hypoxia. Each dot represents a single C. elegans strain tested. Mutant strains related to up-regulated genes are shown in blue, strains related to down-regulated genes in red. The dashed line depicts the performance of wild-type worms. The average SD calculated across all tested strains is depicted in gray. mcp-1 mutant strain is highlighted by an arrow. (F) Comparison of GDPGP1/mcp-1 protein domain and length (in aa) in C. elegans, mouse, and human. Each protein orthologue contains the same domain of unknown function (DUF4922).
Figure 1. RNA-seq identifies the transcriptomic signature of acutely injured neurons. (A) Experimental design to generate a common transcriptomic signature of acutely injured primary mouse neurons. DIV7 neurons prepared from E17 mice were exposed to either OGD or KA. Differentially expressed genes (corrected P values ≤0.01) were determined for each condition. (B) Of 318 similarly regulated and statistically significant genes, 210 were found to be down-regulated and 108 up-regulated due to acute neuronal injury in both in vitro assays. (C) The top 10 up-regulated (blue) and down-regulated (red) genes identified as shared transcriptional signature of acutely injured neurons are depicted along with the mean log2 fold change (FC) and the individual FC for OGD and KA. (D) Flow chart illustrating the selection of identified genes for in vivo validation in C. elegans. (E) Graph indicating the results for 45 individual C. elegans mutant strains with regard to their survival during 48-h period of hypoxia. Each dot represents a single C. elegans strain tested. Mutant strains related to up-regulated genes are shown in blue, strains related to down-regulated genes in red. The dashed line depicts the performance of wild-type worms. The average SD calculated across all tested strains is depicted in gray. mcp-1 mutant strain is highlighted by an arrow. (F) Comparison of GDPGP1/mcp-1 protein domain and length (in aa) in C. elegans, mouse, and human. Each protein orthologue contains the same domain of unknown function (DUF4922).CC BY-NC-SA · PubMed Central
Figure S1. Loss of mcp-1 decreases stress resistance in C. elegans. (A) Survival curves of L4 wild-type C. elegans animals exposed to increasing periods of hypoxia (mean ± SEM; n > 150 worms per time point). (B) Survival of L4 worms of indicated genotypes following 48-h exposure to hypoxia (**, P < 0.01; ***, P < 0.001; all other: nonsignificant; mean ± SEM; n > 100 worms per genotype). (C) Survival of L4 animals of indicated genotypes following 48-h exposure to hypoxia (**, P < 0.01; ns, nonsignificant; mean ± SEM; n > 100 worms per genotype). (D) Survival of L4 worms of indicated genotypes after 48-h exposure to hypoxia (****, P < 0.0001; mean ± SEM; n > 100 worms per genotype). (E) Quantification of axonal beadings per axon in wild-type L4-stage animals exposed to increasing durations of hypoxia, visualized by Punc-47::GFP expression (graph shows mean ± SEM; n > 200 axons per time point). (F) Representative fluorescent micrograph depicting axon breakage and fragmentation of GABAergic motor neurons in mcp-1 mutant animals. Visualized by Punc-47::GFP. Inlay is further magnified. Scale bar, 10 µm.
Figure S1. Loss of mcp-1 decreases stress resistance in C. elegans. (A) Survival curves of L4 wild-type C. elegans animals exposed to increasing periods of hypoxia (mean ± SEM; n > 150 worms per time point). (B) Survival of L4 worms of indicated genotypes following 48-h exposure to hypoxia (**, P < 0.01; ***, P < 0.001; all other: nonsignificant; mean ± SEM; n > 100 worms per genotype). (C) Survival of L4 animals of indicated genotypes following 48-h exposure to hypoxia (**, P < 0.01; ns, nonsignificant; mean ± SEM; n > 100 worms per genotype). (D) Survival of L4 worms of indicated genotypes after 48-h exposure to hypoxia (****, P < 0.0001; mean ± SEM; n > 100 worms per genotype). (E) Quantification of axonal beadings per axon in wild-type L4-stage animals exposed to increasing durations of hypoxia, visualized by Punc-47::GFP expression (graph shows mean ± SEM; n > 200 axons per time point). (F) Representative fluorescent micrograph depicting axon breakage and fragmentation of GABAergic motor neurons in mcp-1 mutant animals. Visualized by Punc-47::GFP. Inlay is further magnified. Scale bar, 10 µm.CC BY-NC-SA · PubMed Central
Figure 2. mcp-1 is expressed in C. elegans neurons and is transcriptionally down-regulated during stress. (A) Fluorescent micrographs of animals expressing a transcriptional mcp-1 reporter (Pmcp-1::mCherry). Left: Under normoxic conditions, expression is apparent in neuronal cell bodies (arrowheads), including neurons in the ventral nerve cord (VNC) and in the tail region. DNC, dorsal nerve cord. Right: Exposure to hypoxia (24 h) abolishes expression in cell bodies of most neurons. Scale bar, 50 µm. (B) Quantification of relative fluorescence in Pmcp-1::mCherry animals relative to GFP (Punc-25:GFP; ***, P < 0.001; mean ± SEM). (C–E) Quantitative RT-PCR analysis of mcp-1 transcript levels in animals exposed to hypoxia (C), paraquat (D), and heat stress (E). All values were normalized to control treated animals and compared with actin expression levels (**, P < 0.01; ***, P < 0.001; mean ± SEM).
Figure 2. mcp-1 is expressed in C. elegans neurons and is transcriptionally down-regulated during stress. (A) Fluorescent micrographs of animals expressing a transcriptional mcp-1 reporter (Pmcp-1::mCherry). Left: Under normoxic conditions, expression is apparent in neuronal cell bodies (arrowheads), including neurons in the ventral nerve cord (VNC) and in the tail region. DNC, dorsal nerve cord. Right: Exposure to hypoxia (24 h) abolishes expression in cell bodies of most neurons. Scale bar, 50 µm. (B) Quantification of relative fluorescence in Pmcp-1::mCherry animals relative to GFP (Punc-25:GFP; ***, P < 0.001; mean ± SEM). (C–E) Quantitative RT-PCR analysis of mcp-1 transcript levels in animals exposed to hypoxia (C), paraquat (D), and heat stress (E). All values were normalized to control treated animals and compared with actin expression levels (**, P < 0.01; ***, P < 0.001; mean ± SEM).CC BY-NC-SA · PubMed Central
Figure 3. mcp-1 functions in neurons to increase stress resistance. (A) Survival curves of wild-type and mcp-1(tm2679) mutant animals cultured on standard NGM plates at 25°C (ns, nonsignificant; log-rank test; n > 100 worms per genotype). (B) Survival of animals of indicated genotypes following 48-h exposure to hypoxia (**, P < 0.01; ***, P < 0.001; mean ± SEM; n > 100 worms per genotype). (C) Survival curves of indicated genotypes on paraquat-treated NGM plates at 25°C (*, P < 0.05; **, P < 0.01; log-rank test; n > 80 per genotype). (D) Survival of L4 worms of indicated genotypes following exposure to a 6-h period of heat stress at 35°C (*, P < 0.05; **, P < 0.01; mean ± SEM; n > 100 worms per genotype). (E) Representative fluorescent micrograph image of commissural axons (arrows) of GABA neurons visualized by Punc-47::GFP expression. A single axonal beading is indicated by arrowhead. Scale bar, 20 µm. (F) Quantification of axonal beadings per axon in indicated strains following 32 h of hypoxia (**, P < 0.01; ***, P < 0.001; mean ± SEM; n > 200 axons per genotype).
Figure 3. mcp-1 functions in neurons to increase stress resistance. (A) Survival curves of wild-type and mcp-1(tm2679) mutant animals cultured on standard NGM plates at 25°C (ns, nonsignificant; log-rank test; n > 100 worms per genotype). (B) Survival of animals of indicated genotypes following 48-h exposure to hypoxia (**, P < 0.01; ***, P < 0.001; mean ± SEM; n > 100 worms per genotype). (C) Survival curves of indicated genotypes on paraquat-treated NGM plates at 25°C (*, P < 0.05; **, P < 0.01; log-rank test; n > 80 per genotype). (D) Survival of L4 worms of indicated genotypes following exposure to a 6-h period of heat stress at 35°C (*, P < 0.05; **, P < 0.01; mean ± SEM; n > 100 worms per genotype). (E) Representative fluorescent micrograph image of commissural axons (arrows) of GABA neurons visualized by Punc-47::GFP expression. A single axonal beading is indicated by arrowhead. Scale bar, 20 µm. (F) Quantification of axonal beadings per axon in indicated strains following 32 h of hypoxia (**, P < 0.01; ***, P < 0.001; mean ± SEM; n > 200 axons per genotype).CC BY-NC-SA · PubMed Central
Figure 4. GDPGP1 is down-regulated by stress, and its knockdown leads to neurodegeneration in mouse neurons. (A and B) Quantitative RT-PCR analysis of GDPGP1 transcript levels in DIV7 primary mouse neurons exposed to OGD (A) and paraquat (B). All values were normalized to control treated neurons and compared with actin expression levels (**, P < 0.01; mean ± SEM; n = 3). (C) Immunoblot of cell lysates prepared from DIV7 primary mouse neurons after exposure to OGD and paraquat for GDPGP1 and actin as loading control (n = 3). (D) Representative fluorescent micrographs of cultured primary neurons transfected with either scrambled (shScramble) or GDPGP1-targeted (shGDPGP1) shRNA constructs at two different time points (DIV3 and DIV7). Only transfected, GFP-positive neurons are visualized (GFP is coexpressed in pAAV-U6-GFP vector). Scale bar, 50 µm. (E) Quantification of viable cells in cultures of primary neurons over time (DIV3 to DIV8). Neurons were transfected at DIV0 with scrambled control (shScramble), GDPGP1-targeted (shGDPGP1) shRNA constructs, GDPGP1-targeted shRNA constructs plus the hGDPGP1 coding sequence (shGDPGP1 + hGDPGP1), or GDPGP1-targeted shRNA constructs plus the pan-caspase inhibitor Z-VAD-FMK (shGDPGP1 + Z-VAD-FMK). All values were normalized to control transfected neurons (shScramble) at each time point (**, P < 0.01; ***, P < 0.001; two-way ANOVA for repeated measures with Holm–Sidak post hoc test; n > 250 neurons per genotype and time point; mean ± SEM). (F) Immunoblot of cell lysates prepared from DIV4 primary mouse neurons transfected with either scrambled (shScramble), GDPGP1-targeted (shGDPGP1) shRNA constructs, GDPGP1-targeted shRNA constructs plus the hGDPGP1 coding sequence (shGDPGP1 + hGDPGP1), or GDPGP1-targeted shRNA constructs plus the pan-caspase inhibitor Z-VAD-FMK (shGDPGP1 + Z-VAD-FMK) for cleaved Caspase-3 and actin as loading control. Densitometric quantification of Caspase-3/actin ratio was normalized to shScramble (n = 3).
Figure 4. GDPGP1 is down-regulated by stress, and its knockdown leads to neurodegeneration in mouse neurons. (A and B) Quantitative RT-PCR analysis of GDPGP1 transcript levels in DIV7 primary mouse neurons exposed to OGD (A) and paraquat (B). All values were normalized to control treated neurons and compared with actin expression levels (**, P < 0.01; mean ± SEM; n = 3). (C) Immunoblot of cell lysates prepared from DIV7 primary mouse neurons after exposure to OGD and paraquat for GDPGP1 and actin as loading control (n = 3). (D) Representative fluorescent micrographs of cultured primary neurons transfected with either scrambled (shScramble) or GDPGP1-targeted (shGDPGP1) shRNA constructs at two different time points (DIV3 and DIV7). Only transfected, GFP-positive neurons are visualized (GFP is coexpressed in pAAV-U6-GFP vector). Scale bar, 50 µm. (E) Quantification of viable cells in cultures of primary neurons over time (DIV3 to DIV8). Neurons were transfected at DIV0 with scrambled control (shScramble), GDPGP1-targeted (shGDPGP1) shRNA constructs, GDPGP1-targeted shRNA constructs plus the hGDPGP1 coding sequence (shGDPGP1 + hGDPGP1), or GDPGP1-targeted shRNA constructs plus the pan-caspase inhibitor Z-VAD-FMK (shGDPGP1 + Z-VAD-FMK). All values were normalized to control transfected neurons (shScramble) at each time point (**, P < 0.01; ***, P < 0.001; two-way ANOVA for repeated measures with Holm–Sidak post hoc test; n > 250 neurons per genotype and time point; mean ± SEM). (F) Immunoblot of cell lysates prepared from DIV4 primary mouse neurons transfected with either scrambled (shScramble), GDPGP1-targeted (shGDPGP1) shRNA constructs, GDPGP1-targeted shRNA constructs plus the hGDPGP1 coding sequence (shGDPGP1 + hGDPGP1), or GDPGP1-targeted shRNA constructs plus the pan-caspase inhibitor Z-VAD-FMK (shGDPGP1 + Z-VAD-FMK) for cleaved Caspase-3 and actin as loading control. Densitometric quantification of Caspase-3/actin ratio was normalized to shScramble (n = 3).CC BY-NC-SA · PubMed Central
Figure S2. GDPGP1 knockdown in mouse neurons causes up-regulation of stress-related proteins. (A) Immunocytochemistry of cultured primary neurons. GDPGP1 (red) is labeled along with the neuronal marker βIII spectrin (green). Scale bar, 50 µm. (B) Immunoblot of cell lysates prepared from DIV4 primary mouse neurons transfected with scrambled control (shScramble) or GDPGP1-targeted (shGDPGP1) shRNA constructs for GDPGP1 and actin as loading control (n = 3). (C) The expression profile of various cell stress-related proteins in DIV4 primary mouse neurons was determined (n = 2). Densitometric quantification is shown as median value. (D and E) Dot blots for detection of various cell stress-related proteins used for quantification in Fig. S2 C. Assay overlay is shown as provided by the manufacturer.
Figure S2. GDPGP1 knockdown in mouse neurons causes up-regulation of stress-related proteins. (A) Immunocytochemistry of cultured primary neurons. GDPGP1 (red) is labeled along with the neuronal marker βIII spectrin (green). Scale bar, 50 µm. (B) Immunoblot of cell lysates prepared from DIV4 primary mouse neurons transfected with scrambled control (shScramble) or GDPGP1-targeted (shGDPGP1) shRNA constructs for GDPGP1 and actin as loading control (n = 3). (C) The expression profile of various cell stress-related proteins in DIV4 primary mouse neurons was determined (n = 2). Densitometric quantification is shown as median value. (D and E) Dot blots for detection of various cell stress-related proteins used for quantification in Fig. S2 C. Assay overlay is shown as provided by the manufacturer.CC BY-NC-SA · PubMed Central
Figure 5. Loss of mcp-1/GDPGP1 decreases neuronal glycogen levels. (A) Overview of reactions in glucose metabolism involving glucose-1-P and related metabolites. (B) Quantification of glucose-1-P levels in L4 nematodes of indicated genotypes (*, P < 0.05; mean ± SEM; n = 4). (C) Quantification of glucose-1-P levels in cell lysates prepared from DIV4 primary mouse neurons transfected with scrambled control (shScramble) and GDPGP1-targeted (shGDPGP1) shRNA constructs (*, P < 0.05; mean ± SEM; n = 3). (D) Quantification of glycogen content in L4 nematodes of indicated genotypes (*, P < 0.05; **, P < 0.01; ns, nonsignificant; mean ± SEM; n = 4). (E) Quantification of glycogen content in cell lysates prepared from DIV4 primary mouse neurons transfected with shScramble, GDPGP1-targeted (shGDPGP1) shRNA constructs, or GDPGP1-targeted shRNA constructs plus the hGDPGP1 coding sequence (shGDPGP1 + hGDPGP1; *, P < 0.05; **, P < 0.01; mean ± SEM; n = 3). (F) Quantification of glycogen content in cell lysates prepared from DIV4 primary mouse neurons transfected with vector control or the hGDPGP1 coding sequence (hGDPGP1). Neurons were kept at either standard culture conditions (normoxia) or 6-h hypoxia before lysate preparation (**, P < 0.05; mean ± SEM; n = 3). (G) Quantification of viable cells in cultures of primary neurons over time (DIV3 to DIV8). Neurons were transfected at DIV0 with shScramble, GYS1-targeted (shGYS1) shRNA constructs, or GYS1-targeted shRNA constructs plus the hGYS1 coding sequence (shGYS1 + hGYS1). All values were normalized to control transfected neurons (shScramble) at each time point (**, P < 0.01; ***, P < 0.001; two-way ANOVA for repeated measures with Holm–Sidak post hoc test; n > 150 neurons per genotype and time point; mean ± SEM).
Figure 5. Loss of mcp-1/GDPGP1 decreases neuronal glycogen levels. (A) Overview of reactions in glucose metabolism involving glucose-1-P and related metabolites. (B) Quantification of glucose-1-P levels in L4 nematodes of indicated genotypes (*, P < 0.05; mean ± SEM; n = 4). (C) Quantification of glucose-1-P levels in cell lysates prepared from DIV4 primary mouse neurons transfected with scrambled control (shScramble) and GDPGP1-targeted (shGDPGP1) shRNA constructs (*, P < 0.05; mean ± SEM; n = 3). (D) Quantification of glycogen content in L4 nematodes of indicated genotypes (*, P < 0.05; **, P < 0.01; ns, nonsignificant; mean ± SEM; n = 4). (E) Quantification of glycogen content in cell lysates prepared from DIV4 primary mouse neurons transfected with shScramble, GDPGP1-targeted (shGDPGP1) shRNA constructs, or GDPGP1-targeted shRNA constructs plus the hGDPGP1 coding sequence (shGDPGP1 + hGDPGP1; *, P < 0.05; **, P < 0.01; mean ± SEM; n = 3). (F) Quantification of glycogen content in cell lysates prepared from DIV4 primary mouse neurons transfected with vector control or the hGDPGP1 coding sequence (hGDPGP1). Neurons were kept at either standard culture conditions (normoxia) or 6-h hypoxia before lysate preparation (**, P < 0.05; mean ± SEM; n = 3). (G) Quantification of viable cells in cultures of primary neurons over time (DIV3 to DIV8). Neurons were transfected at DIV0 with shScramble, GYS1-targeted (shGYS1) shRNA constructs, or GYS1-targeted shRNA constructs plus the hGYS1 coding sequence (shGYS1 + hGYS1). All values were normalized to control transfected neurons (shScramble) at each time point (**, P < 0.01; ***, P < 0.001; two-way ANOVA for repeated measures with Holm–Sidak post hoc test; n > 150 neurons per genotype and time point; mean ± SEM).CC BY-NC-SA · PubMed Central
Figure S3. Loss of GDPGP1/mcp-1 does not alter glucose-6-P and pyruvate levels. (A) Quantification of glucose-6-P levels in cell lysates prepared from DIV4 primary mouse neurons transfected with scrambled control (shScramble) and GDPGP1-targeted (shGDPGP1) shRNA constructs (ns, nonsignificant; mean ± SEM; n = 3). (B) Quantification of glucose-6-P levels in L4 animals of indicated genotypes (mean ± SEM; n = 4). (C) Quantification of pyruvate levels in cell lysates prepared from DIV4 primary mouse neurons transfected with shScramble and GDPGP1-targeted (shGDPGP1) shRNA constructs (mean ± SEM; n = 3). (D) Quantification of pyruvate concentration in L4 animals of indicated genotypes (mean ± SEM; n = 3). (E) Survival of L4 worms of indicated genotypes following 48-h exposure to hypoxia (***, P < 0.001; mean ± SEM; n > 100 worms per genotype). (F) Quantification of glycogen content in L4 nematodes of indicated genotypes (*, P < 0.05; **, P < 0.01; mean ± SEM; n = 4). (G) Survival of L4 wild-type and pygl-1(tm5211) mutant worms following 48-h exposure to hypoxia (**, P < 0.01; mean ± SEM; n > 100 worms per genotype).
Figure S3. Loss of GDPGP1/mcp-1 does not alter glucose-6-P and pyruvate levels. (A) Quantification of glucose-6-P levels in cell lysates prepared from DIV4 primary mouse neurons transfected with scrambled control (shScramble) and GDPGP1-targeted (shGDPGP1) shRNA constructs (ns, nonsignificant; mean ± SEM; n = 3). (B) Quantification of glucose-6-P levels in L4 animals of indicated genotypes (mean ± SEM; n = 4). (C) Quantification of pyruvate levels in cell lysates prepared from DIV4 primary mouse neurons transfected with shScramble and GDPGP1-targeted (shGDPGP1) shRNA constructs (mean ± SEM; n = 3). (D) Quantification of pyruvate concentration in L4 animals of indicated genotypes (mean ± SEM; n = 3). (E) Survival of L4 worms of indicated genotypes following 48-h exposure to hypoxia (***, P < 0.001; mean ± SEM; n > 100 worms per genotype). (F) Quantification of glycogen content in L4 nematodes of indicated genotypes (*, P < 0.05; **, P < 0.01; mean ± SEM; n = 4). (G) Survival of L4 wild-type and pygl-1(tm5211) mutant worms following 48-h exposure to hypoxia (**, P < 0.01; mean ± SEM; n > 100 worms per genotype).CC BY-NC-SA · PubMed Central
Figure 6. mcp-1 is neuroprotective in a C. elegans tauopathy model. (A) Representative fluorescent micrograph of control and Paex-3::htauV337M nematodes at L4 stage. GABA nervous system is visualized by Punc-25::GFP. GABA neuron cell bodies can be identified in the ventral nerve cord (VNC). Discontinuities in the dorsal nerve cord (DNC) of Paex-3::htauV337M worms are indicated by arrows. Scale bar, 50 µm. (B) Quantitative RT-PCR analysis of mcp-1 transcript levels in wild-type, Paex-3::htau, and Paex-3::htauV337M nematodes at L4 stage. All values were normalized to wild-type animals and compared with actin expression levels (*, P < 0.05; **, P < 0.01; mean ± SEM). (C) Quantification of glycogen content in L4 wild-type, Paex-3::htau, and Paex-3::htauV337M nematodes (*, P < 0.05; ***, P < 0.001; mean ± SEM; n = 3). (D) Representative photographs of freely moving individual worms of indicated genotypes on NGM plates. Black brackets highlight the tracks left by worm locomotion. Scale bar, 1 mm. (E) Quantification of movement performance of indicated strains by recording the number of thrashes performed in 30 s at two different time points (***, P < 0.001; ns, nonsignificant; mean ± SEM; n > 20 worms per genotype and time point). (F) Measurement of disrupted GABA axons in indicated strains per animal (**, P < 0.01; ***, P < 0.001; mean ± SEM; n > 20 worms per genotype and time point).
Figure 6. mcp-1 is neuroprotective in a C. elegans tauopathy model. (A) Representative fluorescent micrograph of control and Paex-3::htauV337M nematodes at L4 stage. GABA nervous system is visualized by Punc-25::GFP. GABA neuron cell bodies can be identified in the ventral nerve cord (VNC). Discontinuities in the dorsal nerve cord (DNC) of Paex-3::htauV337M worms are indicated by arrows. Scale bar, 50 µm. (B) Quantitative RT-PCR analysis of mcp-1 transcript levels in wild-type, Paex-3::htau, and Paex-3::htauV337M nematodes at L4 stage. All values were normalized to wild-type animals and compared with actin expression levels (*, P < 0.05; **, P < 0.01; mean ± SEM). (C) Quantification of glycogen content in L4 wild-type, Paex-3::htau, and Paex-3::htauV337M nematodes (*, P < 0.05; ***, P < 0.001; mean ± SEM; n = 3). (D) Representative photographs of freely moving individual worms of indicated genotypes on NGM plates. Black brackets highlight the tracks left by worm locomotion. Scale bar, 1 mm. (E) Quantification of movement performance of indicated strains by recording the number of thrashes performed in 30 s at two different time points (***, P < 0.001; ns, nonsignificant; mean ± SEM; n > 20 worms per genotype and time point). (F) Measurement of disrupted GABA axons in indicated strains per animal (**, P < 0.01; ***, P < 0.001; mean ± SEM; n > 20 worms per genotype and time point).CC BY-NC-SA · PubMed Central
Figure 7. Proposed model of GDPGP1/mcp-1’s function in neuronal stress response. Upon injury or damage to neuronal cells, a response program is initiated that involves down-regulation of GDPGP1/mcp-1 transcript and protein levels. GDPGP1/mcp-1 down-regulation results in lower glucose-1-P levels and lower neuronal glycogen content. Reduction of these metabolites causes neurodegeneration and decreases the stress resistance of neurons.
Figure 7. Proposed model of GDPGP1/mcp-1’s function in neuronal stress response. Upon injury or damage to neuronal cells, a response program is initiated that involves down-regulation of GDPGP1/mcp-1 transcript and protein levels. GDPGP1/mcp-1 down-regulation results in lower glucose-1-P levels and lower neuronal glycogen content. Reduction of these metabolites causes neurodegeneration and decreases the stress resistance of neurons.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Research works printed but not linked: 1

  1. Cao, 2017, Comprehensive single-cell transcriptional profiling of a multicellular organism, Science., 357, 661, 10.1126/science.aam8940 · doi:10.1126/science.aam8940 · Paper page

Cited by

Metadata

Authors
Schulz, A., Sekine, Y., Oyeyemi, M. J., Abrams, A. J., Basavaraju, M., Han, S. M., Groth, M., Morrison, H., Strittmatter, S. M., & Hammarlund, M.
Affiliations
  • Yale University (US)
  • Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
Corresponding author
Hammarlund, Marc
Venue
Journal of Cell Biology
Published
2020-01-22
Volume
219
Issue
2
ISSN
  • 0021-9525 (ISSN-L)
  • 1540-8140
OpenAlex
W3001074179
Cited by
14
References
38
Citations by year
2025: 5 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 4
FWCI
0.66
Type
journal article
Language
en
Open access
Locations
  • The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (SCHU 3039/1-1)
  • National Institutes of Health (R01NS098817, R01NS094219, P40 OD010440)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
MCP-1, neuronal survival, neuronal cell death, GABAergic neurons, hypoxia, tauopathy, neurodegeneration, stress-responsive gene expression, Caenorhabditis elegans, mouse neurons
MeSH terms
Animals, Disease Models, Animal, DNA Damage, Glucosyltransferases, Glycogen, Humans, Nerve Degeneration, Neurons, Caenorhabditis elegans, Apoptosis, Caenorhabditis elegans Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.